title: [Drug treatment options in prostatic hyperplasia].
abstract: The following may be briefly stated about the actually known and clinically used pharmacotherapeutic strategies: Among the choices of treatment regimens for benign prostatic hyperplasia drugs are in general of only limited importance. Only early stages of hyperplasia may be successfully treated with drugs. Before and during treatment, however, prostatic cancer has to be excluded. To this end thorough and strict controls are mandatory, questions about the state of health and filling of recipies alone are by no means sufficient.
authors.affiliation: Urologische Klinik, Universitätsspital Zürich.
authors.forename: D
authors.initials: D
authors.lastname: Hauri
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D006728:Hormones; D010936:Plant Extracts